KKRAF yields 1.81% · PFE yields 6.13%● Live data
📍 KKRAF pulled ahead of the other in Year 1
Combined, KKRAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KKRAF + PFE for your $10,000?
Katakura Industries Co.,Ltd. engages in the textile, pharmaceutical, machinery, real estate, and life solutions businesses in Japan. The company manufactures and sells undergarments, hosiery products, aprons, and relaxing garments, as well as various functional fibers, such as the water-soluble fiber solvron and the thermal resistant NITIVY ALF. It also engages in the manufacture and sale of pharmaceuticals for treating cardiovascular illnesses comprising Frandol for the treatment of angina pectoris; and Frandol Tape, a heart medicine. In addition, the company manufactures and sells environment-related equipment (washers) and cutting oilrelated products, fire engines and firefighting-related equipment, and agricultural machinery, as well as car parts. Further, it provides commercial facility management services; and leases and develops various real estate lands. Additionally, the company offers agriculture-related products, food products, nursing care equipment, and general building maintenance and flower/tree planting services, as well as operates plant and pet specialty shops. The company was formerly known as Katakura Silk Spinning Co., Ltd. and changed its name to Katakura Industries Co.,Ltd. in November 1943. Katakura Industries Co.,Ltd. was founded in 1873 and is headquartered in Tokyo, Japan.
Full KKRAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.